Stock

ResMed Inc. (RMD)

NYSE · Healthcare · Medical - Devices

Profile

ResMed Inc.

Exchange
NYSE
Ticker
RMD
Sector
Healthcare
Industry
Medical - Devices
Country
US

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Key facts

ResMed Inc.: key facts

  • ResMed Inc. (NYSE: RMD) is a Medical - Devices company in the Healthcare sector.
  • In fiscal 2026, ResMed Inc. reported revenue of $5.7B and net income of $1.5B.
  • Revenue grew 12.1% a year over the last 4 fiscal years.
  • Free cash flow was positive in 5 of the last 5 fiscal years.
  • Net income was positive in 5 of the last 5 fiscal years.
  • Over the last twelve months, revenue was $5.7B and net income was $1.6B.

MonkScore

ResMed Inc.'s MonkScore

MonkScore

MonkScore range: 90–100

as of October 2026

Sector rank: 73 of 628 in Healthcare

How this score is madeDisclaimer

Pillar ranges

  • Growth80–90
  • Profitability80–90
  • Quality90–100
  • Market Conviction70–80
  • Safety30–40

The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.

Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.

Fundamentals

Figures from the statements

ResMed Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.

FigureLast 12 monthsFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$5.7B$5.7B$5.1B$4.7B$4.2B$3.6B
Gross profit$3.5B$3.5B$3.1B$2.7B$2.4B$2.0B
Operating income$1.9B$1.9B$1.7B$1.3B$1.1B$1.0B
Net income$1.6B$1.5B$1.4B$1.0B$897.6M$779.4M
Operating cash flow$3.1B$1.8B$1.8B$1.4B$693.3M$351.1M
Capital expenditure-$273.2M-$156.3M-$89.9M-$114.9M-$134.0M-$156.0M
Free cash flow$2.8B$1.6B$1.7B$1.3B$559.3M$195.1M
Total debt$610.6M$825.9M$851.8M$873.9M$1.6B$917.6M
Cash$1.0B$1.5B$1.2B$238.4M$227.9M$273.7M

Revenue growth a year

1-year
9.9%
3-year
10.2%
4-year
12.1%

Compound growth between fiscal years.

Peers

Similar companies

See the full analysisResMed Inc.'s exact MonkScore and pillar scores, in the MonkStreet app

Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click

MonkStreet provides research, not investment advice.

Page built on 31 October 2026.